Publication | Closed Access

CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas

Lymphoid NeoplasiaMedicineImmunologyHematologyFront-line ChemotherapyAdult T-cell Leukemia-lymphomaImmunotherapyOncologyRadiation OncologyHealth Sciences